Remasog, Baby Boy .

HRN: 27-59-17  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2025
AMPICILLIN 500MG (VIAL)
08/03/2025
08/09/2025
IVT
130mg
Q12
T/C MAS
Remove - Pending Acceptance
08/03/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
08/03/2025
08/09/2025
IVT
13mg
OD
T/C MAS
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: